1. Home
  2. HOWL vs SGA Comparison

HOWL vs SGA Comparison

Compare HOWL & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • SGA
  • Stock Information
  • Founded
  • HOWL 2017
  • SGA 1986
  • Country
  • HOWL United States
  • SGA United States
  • Employees
  • HOWL N/A
  • SGA N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • SGA Broadcasting
  • Sector
  • HOWL Health Care
  • SGA Consumer Discretionary
  • Exchange
  • HOWL Nasdaq
  • SGA Nasdaq
  • Market Cap
  • HOWL 87.4M
  • SGA 72.0M
  • IPO Year
  • HOWL 2021
  • SGA 1992
  • Fundamental
  • Price
  • HOWL $1.41
  • SGA $12.63
  • Analyst Decision
  • HOWL Strong Buy
  • SGA
  • Analyst Count
  • HOWL 2
  • SGA 0
  • Target Price
  • HOWL $9.50
  • SGA N/A
  • AVG Volume (30 Days)
  • HOWL 280.2K
  • SGA 19.3K
  • Earning Date
  • HOWL 03-06-2025
  • SGA 03-06-2025
  • Dividend Yield
  • HOWL N/A
  • SGA 7.94%
  • EPS Growth
  • HOWL N/A
  • SGA N/A
  • EPS
  • HOWL N/A
  • SGA 0.75
  • Revenue
  • HOWL $3,386,000.00
  • SGA $110,669,000.00
  • Revenue This Year
  • HOWL N/A
  • SGA N/A
  • Revenue Next Year
  • HOWL $34.17
  • SGA $2.64
  • P/E Ratio
  • HOWL N/A
  • SGA $16.91
  • Revenue Growth
  • HOWL N/A
  • SGA N/A
  • 52 Week Low
  • HOWL $1.26
  • SGA $10.75
  • 52 Week High
  • HOWL $8.19
  • SGA $24.70
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.51
  • SGA 63.41
  • Support Level
  • HOWL $1.28
  • SGA $11.57
  • Resistance Level
  • HOWL $1.42
  • SGA $13.02
  • Average True Range (ATR)
  • HOWL 0.09
  • SGA 0.29
  • MACD
  • HOWL 0.01
  • SGA 0.08
  • Stochastic Oscillator
  • HOWL 49.93
  • SGA 82.07

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets and It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

Share on Social Networks: